In the past week, DBD stock has gone down by -54.96%, with a monthly decline of -61.11% and a quarterly plunge of -27.51%. The volatility ratio for the week is 11.09%, and the volatility levels for the last 30 days are 9.85% for Diebold Nixdorf Incorporated The simple moving average for the last 20 days is -58.78% for DBD stock, with a simple moving average of -54.06% for the last 200 days.
Is It Worth Investing in Diebold Nixdorf Incorporated (NYSE: DBD) Right Now?
Moreover, the 36-month beta value for DBD is 3.04. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 2 as “hold,” and 1 as “sell.”
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
The average price recommended by analysts for Diebold Nixdorf Incorporated (DBD) is $4.00, which is $2.77 above the current market price. The public float for DBD is 71.41M and currently, short sellers hold a 11.61% of that float. On March 17, 2023, DBD’s average trading volume was 1.64M shares.
DBD) stock’s latest price update
Diebold Nixdorf Incorporated (NYSE: DBD)’s stock price has decreased by -46.74 compared to its previous closing price of 2.30. However, the company has experienced a -54.96% decline in its stock price over the last five trading sessions.
Analysts’ Opinion of DBD
In the past week, DBD stock has gone down by -54.96%, with a monthly decline of -61.11% and a quarterly plunge of -27.51%. The volatility ratio for the week is 11.09%, and the volatility levels for the last 30 days are 9.85% for Diebold Nixdorf Incorporated The simple moving average for the last 20 days is -58.78% for DBD stock, with a simple moving average of -54.06% for the last 200 days.
Analysts’ Opinion of DBD
Many brokerage firms have already submitted their reports for DBD stocks, with DA Davidson repeating the rating for DBD by listing it as a “Neutral.” The predicted price for DBD in the upcoming period, according to DA Davidson is $3 based on the research report published on October 24th of the previous year 2022.
Wedbush gave a rating of “Outperform” to DBD, setting the target price at $5 in the report published on July 08th of the previous year.
DBD Trading at -51.37% from the 50-Day Moving Average
After a stumble in the market that brought DBD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.88% of loss for the given period.
Volatility was left at 9.85%, however, over the last 30 days, the volatility rate increased by 11.09%, as shares sank -59.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.22% lower at present.
During the last 5 trading sessions, DBD fell by -54.42%, which changed the moving average for the period of 200-days by -60.13% in comparison to the 20-day moving average, which settled at $2.88. In addition, Diebold Nixdorf Incorporated saw -13.73% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DBD starting from GREENFIELD GARY G, who purchase 17,500 shares at the price of $2.88 back on Feb 14. After this action, GREENFIELD GARY G now owns 172,419 shares of Diebold Nixdorf Incorporated, valued at $50,358 using the latest closing price.
Marquez Octavio, the President and CEO of Diebold Nixdorf Incorporated, purchase 7,000 shares at $2.92 during a trade that took place back on Feb 14, which means that Marquez Octavio is holding 358,286 shares at $20,440 based on the most recent closing price.
Stock Fundamentals for DBD
Current profitability levels for the company are sitting at:
- -2.43 for the present operating margin
- +22.48 for the gross margin
The net margin for Diebold Nixdorf Incorporated stands at -16.80. Equity return is now at value 38.00, with -13.10 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.10.
Conclusion
To wrap up, the performance of Diebold Nixdorf Incorporated (DBD) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
